SEC Form 4 · accession 0001209191-17-029537
TRANSENTERIX INC. · TRXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrea Biffi
Director
Period of report
May 3, 2017
Accepted (ET)
May 3, 2017 · 12:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 3, 2017 | P$0 | 250,000 | — | A | 340,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A WarrantsF1,F2 | $1.00 | May 3, 2017 | P | 250,000 | A | May 3, 2017 | May 3, 2018 | Common Stock | 250,000 | 250,000 | D |
| Series B WarrantsF1 | $1.00 | May 3, 2017 | P | 187,500 | A | May 3, 2017 | May 3, 2022 | Common Stock | 187,500 | 187,500 | D |
Explanation of responses
- F1Purchase of units ("Units"), each Unit consisting of one share of the Company's common stock, par value $0.001 per share ("Common Stock"), one Series A warrant to purchase one share of Common Stock, and a Series B warrant to purchase 0.75 shares of Common Stock for a purchase price of $1.00 per Unit.
- F2The expiration date of the Series A warrant may be accelerated, as set forth in the warrant.